A detailed history of Plato Investment Management LTD transactions in United Therapeutics Corp stock. As of the latest transaction made, Plato Investment Management LTD holds 2,594 shares of UTHR stock, worth $1.04 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,594
Previous 4,008 35.28%
Holding current value
$1.04 Million
Previous $1.28 Billion 27.27%
% of portfolio
0.08%
Previous 0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$311.04 - $363.55 $439,810 - $514,059
-1,414 Reduced 35.28%
2,594 $929 Million
Q2 2024

Aug 08, 2024

BUY
$228.26 - $319.04 $60,260 - $84,226
264 Added 7.05%
4,008 $1.28 Billion
Q1 2024

May 14, 2024

BUY
$210.76 - $249.51 $789,085 - $934,165
3,744 New
3,744 $1.32 Billion

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $18.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Plato Investment Management LTD Portfolio

Follow Plato Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plato Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Plato Investment Management LTD with notifications on news.